Literature DB >> 8265601

Catalytic contribution of flap-substrate hydrogen bonds in "HIV-1 protease" explored by chemical synthesis.

M Baca1, S B Kent.   

Abstract

An analogue of "HIV-1 protease" was designed in which the ability to donate important water-mediated hydrogen bonds to substrate was precisely and directly deleted. Chemical ligation of unprotected peptide segments was used to synthesize this "backbone-engineered" enzyme. The functionally relevant amide -CONH- linkage between residues Gly49-Ile50 in each flap of the enzyme was replaced by an isosteric thioester -COS- bond. The backbone-engineered enzyme had normal substrate specificity and affinity (Km). However, the catalytic activity (kcat) was reduced approximately 3000-fold compared to the native amide bond-containing enzyme. Inhibition by the reduced peptide bond substrate analogue MVT-101 was unaffected compared with native enzyme. By contrast, the normally tight-binding hydroxyethylamine inhibitor JG-365 bound to the backbone-engineered enzyme with an approximately 2500-fold reduction in affinity. The reduced catalytic activity of the -Gly49-psi(COS)-Ile50-backbone-engineered enzyme analogue provides direct experimental evidence to support the suggestion that backbone hydrogen bonds from the enzyme flaps to the substrate are important for the catalytic function of the HIV-1 protease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265601      PMCID: PMC48039          DOI: 10.1073/pnas.90.24.11638

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.

Authors:  M A Navia; P M Fitzgerald; B M McKeever; C T Leu; J C Heimbach; W K Herber; I S Sigal; P L Darke; J P Springer
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

3.  The catalytic mechanism of aspartic proteinases.

Authors:  L H Pearl
Journal:  FEBS Lett       Date:  1987-04-06       Impact factor: 4.124

Review 4.  The chemical synthesis of proteins.

Authors:  T W Muir; S B Kent
Journal:  Curr Opin Biotechnol       Date:  1993-08       Impact factor: 9.740

5.  Regression analysis of nonlinear Arrhenius plots: an empirical model and a computer program.

Authors:  R G Duggleby
Journal:  Comput Biol Med       Date:  1984       Impact factor: 4.589

6.  New segment synthesis of alpha-inhibin-92 by the acyl disulfide method.

Authors:  D Yamashiro; C H Li
Journal:  Int J Pept Protein Res       Date:  1988-03

7.  Structural engineering of the HIV-1 protease molecule with a beta-turn mimic of fixed geometry.

Authors:  M Baca; P F Alewood; S B Kent
Journal:  Protein Sci       Date:  1993-07       Impact factor: 6.725

8.  Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides.

Authors:  F A Robey; R L Fields
Journal:  Anal Biochem       Date:  1989-03       Impact factor: 3.365

Review 9.  Inhibitors of HIV-1 protease.

Authors:  T D Meek
Journal:  J Enzyme Inhib       Date:  1992

10.  Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.

Authors:  J Schneider; S B Kent
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

View more
  10 in total

1.  Protein conformational dynamics in the mechanism of HIV-1 protease catalysis.

Authors:  Vladimir Yu Torbeev; H Raghuraman; Donald Hamelberg; Marco Tonelli; William M Westler; Eduardo Perozo; Stephen B H Kent
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-08       Impact factor: 11.205

2.  Accelerated chemical synthesis of peptides and small proteins.

Authors:  L P Miranda; P F Alewood
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

3.  Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants.

Authors:  W Shao; L Everitt; M Manchester; D D Loeb; C A Hutchison; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Xenoprotein engineering via synthetic libraries.

Authors:  Zachary P Gates; Alexander A Vinogradov; Anthony J Quartararo; Anupam Bandyopadhyay; Zi-Ning Choo; Ethan D Evans; Kathryn H Halloran; Alexander J Mijalis; Surin K Mong; Mark D Simon; Eric A Standley; Evan D Styduhar; Sarah Z Tasker; Faycal Touti; Jessica M Weber; Jessica L Wilson; Timothy F Jamison; Bradley L Pentelute
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

Review 5.  Novel protein science enabled by total chemical synthesis.

Authors:  Stephen B H Kent
Journal:  Protein Sci       Date:  2018-12-18       Impact factor: 6.725

Review 6.  The early years of retroviral protease crystal structures.

Authors:  Maria Miller
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

7.  A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.

Authors:  Marc Potempa; Ellen Nalivaika; Debra Ragland; Sook-Kyung Lee; Celia A Schiffer; Ronald Swanstrom
Journal:  J Mol Biol       Date:  2015-05-15       Impact factor: 5.469

8.  Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations.

Authors:  Stefano Piana; Paolo Carloni; Ursula Rothlisberger
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

9.  A poke in the eye: inhibiting HIV-1 protease through its flap-recognition pocket.

Authors:  Kelly L Damm; Peter M U Ung; Jerome J Quintero; Jason E Gestwicki; Heather A Carlson
Journal:  Biopolymers       Date:  2008-08       Impact factor: 2.505

10.  Solid-phase synthesis of peptidyl thioacids employing a 9-fluorenylmethyl thioester-based linker in conjunction with Boc chemistry.

Authors:  David Crich; Kasinath Sana
Journal:  J Org Chem       Date:  2009-10-02       Impact factor: 4.354

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.